The role of endoscopy in the assessment and treatment of esophageal cancer

Gastrointestinal Endoscopy

Volumn 57, Issue 7, 2003, Pages 817-822

  Jacobson, Brian C ^a   Hirota, William ^a   Baron, Todd H ^a   Leighton, Jonathan A ^a   Faigel, Douglas O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CAUTERIZATION; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE COST; HUMAN; MORBIDITY; MORTALITY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ELECTROCOAGULATION; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS TUMOR; PATHOLOGY; PHOTOCHEMOTHERAPY; PRACTICE GUIDELINE; STENT;

ELECTROCOAGULATION; ENDOSCOPY, GASTROINTESTINAL; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; STENTS;

EID: 0141610146     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(03)70048-0     Document Type: Article

References (76)

1. Jemal A., Thomas A., Murray T., and Thun M. Cancer statistics. CA Cancer J Clin 52 (2002) 23-47
2. Pera M., Cameron A., Trastek V., Carpenter H., and Zinsmeister A. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104 (1993) 510-513
3. Reid B., Weinstein W., Lewin K., Haggitt R., VanDeventer G., DenBesten L., et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 94 (1988) 81-90
4. Dulai G., Guha S., Kahn K., Gornbein J., and Weinstein W. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 122 (2002) 26-33
5. American Society for Gastrointestinal Endoscopy Standards of Practice Committee. Ultrathin endoscopes esophagogastroduodenoscopy. Gastrointest Endosc 51 (2000) 786-789
6. Mulcahy H., and Fairclough P. Ultrathin endoscopy in the assessment and treatment of upper and lower gastrointestinal tract strictures. Gastrointest Endosc 48 (1998) 618-620
7. Sugimachi K., Kitamura K., Baba K., Ikebe M., and Kuwano H. Endoscopic diagnosis of early carcinoma of the esophagus using Lugol's solution. Gastrointest Endosc 38 (1992) 657-661
8. Inoue H., Rey J., and Lightdale C. Lugol chromoendoscopy for esophageal squamous cell cancer. Endoscopy 33 (2001) 75-79
9. Wo J., Ray M., Mayfield-Stokes S., Al-Sabbagh G., Gebrail F., Slone S., et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a preliminary study. Gastrointest Endosc 54 (2001) 294-301
10. Canto M., Setrakian S., Willis J., Chak A., Petras R., Powe N., et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 51 (2000) 560-568
11. Graham D., Schwartz J., Cain G., and Gyorkey F. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology 82 (1982) 228-231
12. Zargar S., Khuroo M., Jan G., Mahajan R., and Shah P. Prospective comparison of the value of brushings before and after biopsy in the endoscopic diagnosis of gastroesophageal malignancy. Acta Cytol 35 (1991) 549-552
13. Winawer S., Sherlock P., Belladonna J., Melamed M., and Beattie E. Endoscopic brush cytology in esophageal cancer. JAMA 232 (1975) 1358
14. Dekker W., and Tytgat G. Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. A follow-up analysis. Gastroenterology 73 (1977) 710-714
15. Falk G., Rice T., Goldblum J., and Richter J. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 49 (1999) 170-176
16. Kobayashi S., and Kasugai T. Brushing cytology for the diagnosis of gastric cancer involving the cardia or the lower esophagus. Acta Cytol 22 (1978) 155-157
17. Faigel D., Deveney C., Phillips D., and Fennerty M. Biopsy-negative malignant esophageal stricture: diagnosis by endoscopic ultrasound. Am J Gastroenterol 93 (1998) 2257-2260
18. Sobin L., and Wittekind C. TNM Classification of malignant tumours. 6th ed (2002), John Wiley and Sons, UICC. New York
19. Fleming I., Cooper J., Henson D., et al. AJCC cancer staging handbook. 5th ed (1998), Lippincott-Raven, Philadelphia
20. Mallery S., and VanDam J. EUS in the evaluation of esophageal carcinoma. Gastrointest Endosc 52 Suppl (2000) S6-S11
21. Hiele M., Leyn P., Schurmans P., Lerut A., Huys S., Geboes K., et al. Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction. Gastrointest Endosc 45 (1997) 381-386
22. Shumaker D., de Garmo P., and Faigel D. Potential impact of preoperative EUS on esophageal cancer management and cost. Gastrointest Endosc 56 (2002) 391-396
23. Rösch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin North Am 5 (1995) 537-547
24. Rösch T., and Classen M. Staging ESOPHAGEAL CANCER: THE MUNICH EXPERIENCE. In: Van Dam J., and Sivak M. (Eds). Gastrointestinal endosonography (1999), WB Saunders, Philadelphia
25. Menzel J., Hoepffner N., Nottberg H., Schulz C., Senninger N., and Domschke W. Preoperative staging of esophageal carcinoma: miniprobe sonography versus conventional endoscopic ultrasound in a prospective histopathologically verified study. Gastrointest Endosc 31 (1999) 291-297
26. Hasegawa N., Niwa Y., Arisawa T., Hase S., Goto H., and Hayakawa T. Preoperative staging of superficial esophageal carcinoma: a comparison of an ultrasound probe and standard endoscopic ultrasonography. Gastrointest Endosc 44 (1996) 388-393
27. Murata Y., Suzuki S., Ohta M., Mitsunaga A., Hayashi K., Yoshida K., et al. Small ultrasonic probes for determination of the depth of superficial esophageal cancer. Gastrointest Endosc 44 (1996) 23-28
28. Catalano M., Sivak M., Rice T., Gragg L., and Van Dam J. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 40 (1994) 442-446
29. Faigel D. EUS in patients with benign and malignant lymphadenopathy. Gastrointest Endosc 53 (2001) 593-598
30. Bhutani M., Hawes R., and Hoffman B. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for the diagnosis of malignant lymph node invasion. Gastrointest Endosc 45 (1997) 474-479
31. Eloubeidi M., Wallace M., Reed C., Hadzijahic N., Lewin D., Van Velse A., et al. The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single center experience. Gastrointest Endosc 54 (2001) 714-719
32. Vazquez-Sequeiros E., Norton I., Clain J., Wang K., Affi A., Allen M., et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 53 (2001) 751-757
33. Wallace M., Kennedy T., Durkalski V., Eloubeidi M., Etamad R., Matsuda K., et al. Randomized controlled trial of EUS-guided fine needle aspiration techniques for the detection of malignant lymphadenopathy. Gastrointest Endosc 54 (2001) 441-447
34. Mallery S., and Van Dam J. Increased rate of complete EUS staging of patients with esophageal cancer using the non-optical, wire-guided echoendoscope. Gastrointest Endosc 50 (1999) 53-57
35. Van Dam J., Rice T., Catalano M., Kirby T., and Sivak M. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 71 (1993) 2910-2917
36. Catalano M., Vandam J., and Sivak M. Malignant esophageal strictures: staging accuracy of endoscopic ultrasonography. Gastrointest Endosc 41 (1995) 535-539
37. Fockens P., van Dulleman H., and Tytgat G. Endosonography of stenotic esophageal carcinomas: preliminary experience with an ultra-thin, balloon-fitted ultrasound probe in four patients. Gastrointest Endosc 40 (1994) 226-228
38. Chak A., Canto M., Stevens P., Lightdale C., Van de Mierop F., Cooper G., et al. Clinical applications of a new through-the-scope ultrasound probe: prospective comparison with an ultrasound endoscope. Gastrointest Endosc 45 (1997) 291-295
39. Kallimanis G., Gupta P., al-Kawas F., Tio L., Benjamin S., Bertagnolli M., et al. Endoscopic ultrasound for staging esophageal cancer, with or without dilation, is clinically important and safe. Gastrointest Endosc 41 (1995) 540-546
40. Wallace M., Hawes R., Sahai A., Van Velse A., and Hoffman B. Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management. Gastrointest Endosc 51 (2000) 309-313
41. Pfau P., Ginsberg G., Lew R., Faigel D., Smith D., and Kochman M. Esophageal dilation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol 95 (2000) 2813-2815
42. Laterza E., de Manzoni G., Guglielmi A., Rodella L., Tedesco P., and Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 67 (1999) 1466-1469
43. Isenberg G., Chak A., Canto M., Levitan N., Clayman J., Pollack B., et al. Endoscopic ultrasound in re-staging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest Endosc 48 (1998) 158-163
44. Zuccaro G., Rice T., Goldblum J., Medendorp S., Becker M., Pimentel R., et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 94 (1999) 906-912
45. Willis J., Cooper G., Isenberg G., Sivak M., Levitan N., Clayman J., et al. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc 55 (2002) 655-661
46. Chak A., Canto M., Cooper G., Isenberg G., Willis J., Levitan N., et al. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 88 (2000) 1788-1795
47. Catalano M., Sivak M., Rice T., and Van Dam J. Postoperative screening for anastamotic recurrence of esophageal carcinoma by endoscopic ultrasonography. Gastrointest Endosc 42 (1995) 540-544
48. Fockens P., Manshanden C., van Lanschot J., Obertop H., and Tytgat G. Prospective study on the value of endosonographic follow-up after surgery for esophageal carcinoma. Gastrointest Endosc 46 (1997) 487-491
49. Lightdale CJ. Esophageal Cancer. Am J Gastroenterol 94 (1999) 20-29
50. Walsh T., Noonan N., Hollywood D., Kelly A., Keeling N., and Hennessy P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 509-510
51. Bossett J., Gignoux M., Triboulet J., Tiret E., Mantion G., Elias D., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
52. Adler D., and Baron T. Endoscopic palliation of malignant dysphagia. Mayo Clin Proc 76 (2001) 731-738
53. Hernandez L., Jacobson J., and Harris M. Comparison among the perforation rates of Maloney, balloon, and Savary dilation of esophageal strictures. Gastrointest Endosc 51 (2000) 460-462
54. Baron T. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344 (2001) 1681-1687
55. Knyrim K., Wagner H., Bethge N., Keymling M., and Vakil N. A controlled trial of an expansile stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 329 (1993) 302-307
56. Siersema P., Schrauwen S., Blankenstein M., Steyerberg E., van der Gaast A., Tilanus H., et al. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 54 (2001) 579-586
57. Ramirez F., Dennert B., Zierer S., and Sanowski R. Esophageal self-expandable metallic stents- indications, practice, techniques, and complications: results of a national survey. Gastrointest Endosc 45 (1997) 360-364
58. Kinsman K., DeGregorio B., Katon R., Morrison K., Saxon R., Keller F., et al. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stent for esophagogastric malignancy. Gastrointest Endosc 43 (1996) 196-203
59. Bethge N., Sommer A., and Vakil N. A prospective trial of self-expanding metal stents in the palliation of malignant esophageal strictures near the upper esophageal sphincter. Gastrointest Endosc 45 (1997) 300-303
60. Dua K., Kozarek R., Kim J., Evans J., Medda B., Lang I., et al. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc 53 (2001) 603-613
61. Raijman I., Siddique I., Ajani J., and Lynch P. Palliation of malignant dysphagia and fistulae with coated expanded metal stents: experience with 101 patients. Gastrointest Endosc 48 (1998) 172-179
62. Johnston J., Fleischer D., Petrini J., and Nord H. Palliative bipolar electrocoagulation therapy of obstruction of esophagal cancer. Gastrointest Endosc 33 (1987) 349-353
63. Heindorff H., Wojdemann M., Bisgaard T., and Svendsen L. Endoscopic palliation of inoperable cancer of the esophagus or cardia by argon plasma electrocoagulation. Scand J Gastroenterol 33 (1998) 21-23
64. Lightdale C., Zimbalist E., and Winawer S. Outpatient management of esophageal cancer with endoscopic Nd:YAG laser. Am J Gastroenterol 82 (1987) 46-50
65. Payne-James J., Spiller R., Misiewicz J., and Silk D. Use of ethanol-induced tumor necrosis to palliate dysphagia in patients with esophagogastric cancer. Gastrointest Endosc 36 (1990) 43-46
66. Heier S., Rothman K., Heier L., and Rosenthal W. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy. Gastroenterology 109 (1995) 63-72
67. Raijman I., Lalor E., and Marcon N. Photodynamic therapy for tumor ingrowth through an expandable esophageal stent. Gastrointest Endosc 41 (1995) 73-74
68. Lightdale C., Heier S., Marcon N., Haber G., Kandel G., Kortan P., et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 42 (1995) 507-512
69. Holscher A., Bollschweller E., Schroder W., Gutschow C., and Siewert J. Prognostic differences between early squamous cell and adenocarcinoma of the esophagus. Dis Esophagus 10 (1997) 179-184
70. Heitmiller R., Redmond M., and Hamilton S. Barrett's esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy. Ann Surg 224 (1996) 66-71
71. Ell C., May A., Gossner L., Pech O., Gunter E., Mayer G., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118 (2000) 670-677
72. Shimizu Y., Tsukagoshi H., Fujita M., Hosokawa M., Kato M., and Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc 56 (2002) 387-390
73. Nijhawan P., and Wang K. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc 52 (2000) 328-332
74. Dallal H., Smith G., Grieve D., Ghosh S., Penman I., and Palmer K. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 54 (2001) 549-557
75. Carazzone A., Bonavina L., Segalin A., Ceriani C., and Peracchia A. Endoscopic palliation of oesophageal cancer: results of a prospective comparison of Nd:YAG laser and ethanol injection. Eur J Surg 165 (1999) 351-356
76. Adam A., Ellul J., Watkinson A., Tan B., Morgan R., Saunders M., et al. Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology 202 (1997) 344-348